venlafaxine hydrochloride has been researched along with escitalopram in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 7 (100.00) | 2.80 |
Authors | Studies |
---|---|
Haas, DM; Marks, C; Quinney, SK; Silvola, R; Teal, E | 1 |
Koziorowski, M; Mytych, J; Sołek, P; Tabęcka-Łonczyńska, A | 1 |
Chen, J; Lan, X; Lao, G; Li, G; Li, W; Ning, Y; Wang, C; Wu, K; Zhang, M; Zhang, Z; Zhou, Y | 1 |
Cipelli, R; Dell'Osso, B; Di Nicola, M; Martinotti, G; Peduto, I; Pugliese, AC; Signorelli, MS; Ventriglio, A | 1 |
Cao, Q; Rao, Y; Yang, R; Zhao, J | 1 |
Haugen, F; Kaplan-Arabaci, O; Kondratskaya, E; Paulsen, RE; Zosen, D | 1 |
Bhatele, P; Chand Sarangi, S; Dwivedi, R; Elavarasi, A; Kalaivani, M; Kumar Singh, R; Prarthana Chandra, P; Sagar, R; Tripathi, M; Vibha, D | 1 |
1 review(s) available for venlafaxine hydrochloride and escitalopram
Article | Year |
---|---|
Efficacy and tolerability of antidepressant drugs in treatment of depression in children and adolescents: a network meta-analysis.
Topics: Adolescent; Amitriptyline; Antidepressive Agents; Child; Depression; Depressive Disorder, Major; Duloxetine Hydrochloride; Escitalopram; Fluoxetine; Humans; Imipramine; Network Meta-Analysis; Paroxetine; Sertraline; Venlafaxine Hydrochloride | 2022 |
1 trial(s) available for venlafaxine hydrochloride and escitalopram
Article | Year |
---|---|
VE-MMODE - A randomized controlled trial of Venlafaxine versus Escitalopram for treatment of mild to moderate depression in persons with epilepsy.
Topics: Adolescent; Depression; Double-Blind Method; Epilepsy; Escitalopram; Humans; Seizures; Treatment Outcome; Venlafaxine Hydrochloride | 2023 |
5 other study(ies) available for venlafaxine hydrochloride and escitalopram
Article | Year |
---|---|
Comparing newborn outcomes after prenatal exposure to individual antidepressants: A retrospective cohort study.
Topics: Antidepressive Agents; Bupropion; Citalopram; Duloxetine Hydrochloride; Escitalopram; Female; Fluoxetine; Humans; Infant, Newborn; Pregnancy; Prenatal Exposure Delayed Effects; Retrospective Studies; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2021 |
Molecular Consequences of Depression Treatment: A Potential In Vitro Mechanism for Antidepressants-Induced Reprotoxic Side Effects.
Topics: Amitriptyline; Animals; Antidepressive Agents; Antipsychotic Agents; Cell Line; Escitalopram; Fluoxetine; G2 Phase Cell Cycle Checkpoints; Gene Expression Regulation; Imipramine; Male; Mice; Micronuclei, Chromosome-Defective; Mirtazapine; Models, Biological; Olanzapine; Organ Specificity; Reboxetine; Reproduction; Signal Transduction; Spermatogenesis; Telomeric Repeat Binding Protein 1; Telomeric Repeat Binding Protein 2; Time Factors; Venlafaxine Hydrochloride | 2021 |
Predictors of 4-week antidepressant outcome in patients with first-episode major depressive disorder: An ROC curve analysis.
Topics: Antidepressive Agents; Depressive Disorder, Major; Escitalopram; Humans; ROC Curve; Treatment Outcome; Venlafaxine Hydrochloride | 2022 |
Adherence to, and Persistence of, Antidepressant Therapy in Patients with Major Depressive Disorder: Results from a Population-based Study in Italy.
Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Duloxetine Hydrochloride; Escitalopram; Humans; Italy; Paroxetine; Retrospective Studies; Sertraline; Venlafaxine Hydrochloride; Vortioxetine | 2023 |
Antidepressants escitalopram and venlafaxine up-regulate BDNF promoter IV but down-regulate neurite outgrowth in differentiating SH-SY5Y neurons.
Topics: Antidepressive Agents; Brain-Derived Neurotrophic Factor; Cell Differentiation; Cell Line, Tumor; Child; Escitalopram; Female; Humans; Neuroblastoma; Neuronal Outgrowth; Neurons; Pregnancy; Venlafaxine Hydrochloride | 2023 |